tiprankstipranks
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market
IMUC
ImmunoCellular Therapeutics
RESEARCH TOOLSreports

ImmunoCellular Therapeutics (IMUC) Financial Statements

186 Followers

ImmunoCellular Therapeutics Financial Overview

ImmunoCellular Therapeutics's market cap is currently $11.84M. The company's EPS TTM is $; its P/E ratio is -4.67; ImmunoCellular Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -1.83M$ -2.01M$ -1.65M$ -2.89M$ -2.61M
EBITDA$ -1.83M$ -929.09K$ -999.29K$ -2.21M$ -1.00
Net Income$ -1.92M$ -1.89M$ -1.61M$ -2.65M$ -2.68M
Balance Sheet
Cash & Short-Term Investments$ 29.76K$ 98.67K$ 278.26K$ 613.24K$ 1.49M
Total Assets$ 99.46K$ 389.67K$ 409.42K$ 768.80K$ 1.67M
Total Debt$ 1.76M$ 441.88K$ 4.74M$ 3.47M$ 2.82M
Net Debt$ 1.73M$ 343.21K$ 4.46M$ 2.85M$ 1.33M
Total Liabilities$ 2.49M$ 1.01M$ 6.10M$ 4.96M$ 3.28M
Stockholders' Equity$ -2.39M$ -617.86K$ -5.69M$ -4.19M$ -1.62M
Cash Flow
Free Cash Flow$ -1.49M$ -2.68M$ -1.42M$ -2.62M$ -2.31M
Operating Cash Flow$ -1.49M$ -2.68M$ -1.42M$ -2.62M$ -2.31M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 1.43M$ 2.50M$ 1.09M$ 1.75M$ 3.53M
Currency in USD

ImmunoCellular Therapeutics Earnings and Revenue History

Income Statement >

ImmunoCellular Therapeutics Debt to Assets

Balance Sheet >

ImmunoCellular Therapeutics Cash Flow

Cash Flow >

ImmunoCellular Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >